Placental alpha microglobulin-1 (PartoSure) test for the prediction of preterm birth: a systematic review and meta-analysis

References

• Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Sem Fetal Neonatal Med. 2016;21(2):68.
   PubMed Web of Science ®Google Scholar
• Kirby RS. Contribution of cost of preterm infants to the total cost of infant health care in the United States. Pediatrics. 2017;140(4):e20172240.
   PubMed Web of Science ®Google Scholar
• Lee SE, Park JS, Norwitz ER, et al. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol. 2007;109(3):634–640.
   PubMed Web of Science ®Google Scholar
• Lee SM, Lee J, Seong HS, et al. The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med. 2009;22(4):305–310.
   PubMed Web of Science ®Google Scholar
• Lee SM, Romero R, Park JW, et al. The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med. 2012;25(9):1690–1698.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Papageorghiou AT, Kennedy SH, et al. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2011;118(9):1042–1054.
   PubMed Web of Science ®Google Scholar
• Nikolova T, Bayev O, Nikolova N, et al. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery. J Perinat Med. 2014;42(4):473–477.
   PubMed Web of Science ®Google Scholar
• Nikolova T, Bayev O, Nikolova N, et al. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 2015;43(4):395–402.
   PubMed Web of Science ®Google Scholar
• Fatkullin I, Akhmetgaliev A, Matveeva E, et al. Utilization of a novel biomarker test (PartoSure PAMG-1) to reduce the length of stay in patients with threatened preterm labor and a short cervix. J Matern Fetal Neonat Med. 2016;29(1):283–289.
   PubMed Web of Science ®Google Scholar
• Hadzi-Lega M, Maier JT, Helmer H, et al. Comparison of PAMG-1 and phIGFBP-1 tests for the prediction of preterm delivery in patients with preterm labor. OJOG. 2017;07(03):358–368.
   Google Scholar
• Konoplyannikov A, Lysyuk I, Sokolyan A, et al. PAMG-1 biomarker test (PARTOSURE) in combination with transvaginal ultrasound for improved assessment of spontaneous preterm birth in patients with threatened preterm labor. J Matern Fetal Neonat Med. 2016;29(1):278.
   Google Scholar
• Lotfi G, Faraz S, Al Swalhee N, et al. Evaluation of PAMG −1 for the prediction of preterm birth in patients symptomatic of preterm labor. J Perinat Med. 2015;43(S1):432–1299.
   Google Scholar
• Leeflang MMG, Deeks JJ, Takwoingi Y, et al. Cochrane diagnostic test accuracy reviews. Syst Rev. 2013;2(1):82.
   PubMedGoogle Scholar
• Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. The Stata J. 2009;9(2):211–229.
   Web of Science ®Google Scholar
• Bolotskikh V, Borisova V. The role of PAMG-1 protein and ultrasound cervicometry in detection of spontaneous preterm labour. Obstet Gynecol. 2015;2(2):94–98.
   Google Scholar
• Bolotskikh V, Borisova V. Combined value of placental alpha microglobulin-1 detection and cervical length via transvaginal ultrasound in the diagnosis of preterm labor in symptomatic patients. J Obstet Gynaecol Res. 2017;43(8):1263–1269.
   PubMed Web of Science ®Google Scholar
• Caroline VH, Annick C. Comparison of the fetal fibronectin (rapid Ffn) and placental alpha microglobulin-1 (PartoSure) tests for predicting imminent spontaneous preterm birth in patients with threatened preterm labor. J Perinat Med. 2015;43(s1):352.
   Google Scholar
• Çekmez Y, Kıran G, Haberal ET, et al. Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth. BMC Pregn Childbirth. 2017;17(1):246.
   PubMed Web of Science ®Google Scholar
• Lou YY, Ajay B. Is Partosure effective in assessing preterm birth? BJOG Int J Obstet Gynaecol. 2016;123(s1):89.
   Google Scholar
• Melchor J, Navas H, Marcos M, et al. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Ultrasound Obstet Gynecol. 2018;51(5):644–649.
   Google Scholar
• Nikolova T, Uotila J, Nikolova N, et al. 16: Do PAMG-1 or phIGFBP-1 biomarkers improve the prediction of imminent spontaneous preterm delivery in PTL symptomatic women with non-obvious cervical length (CL)? Am J Obstet Gynecol. 2017;216(1):S11–S12.
   Web of Science ®Google Scholar
• Van Holsbeke C, Dam K, Staelens A, et al. OP11.04: comparison of the fetal fibronectin (Rapid fFN) and placental alpha microglobulin-1 (PartoSure) tests for predicting imminent spontaneous preterm birth. Ultrasound Obstet Gynecol. 2016;48(6):809–816.
   PubMed Web of Science ®Google Scholar
• Lotfi G, Faraz S, Nasir R, et al. Comparison of the effectiveness of a PAMG-1 test and standard clinical assessment in the prediction of preterm birth and reduction of unnecessary hospital admissions. J Matern Fetal Neonatal Med. 2019;32(5):793–797.
   PubMed Web of Science ®Google Scholar
• Ravi M, Beljorie M, El Masry K. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor. J Matern Fetal Neonatal Med. 2019;32(23):3909–3914.
   PubMed Web of Science ®Google Scholar
• Nikolova T, Uotila J, Nikolova N, et al. Prediction of spontaneous preterm delivery in women presenting with premature labor: a comparison of placenta alpha microglobulin-1, phosphorylated insulin-like growth factor binding protein-1, and cervical length. Am J Obstet Gynecol. 2018;219(6):610.e1–610.e9.
   Web of Science ®Google Scholar
• Santipap M, Phupong V. Combination of three-dimensional ultrasound measurement of foetal adrenal gland enlargement and placental alpha microglobulin-1 for the prediction of the timing of delivery within seven days in women with threatened preterm labour and preterm labour. J Obstet Gynaecol. 2018;38(8):1054–1059.
   PubMedGoogle Scholar
• Wing DA, Haeri S, Silber AC, et al. Placental alpha microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol. 2017;130(6):1183–1191.
   PubMed Web of Science ®Google Scholar
• Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2016;215(4):431–438.
   PubMed Web of Science ®Google Scholar
• Macones GA. Fetal fibronectin testing in threatened preterm labor: time to stop. Am J Obstet Gynecol. 2016;215(4):405.
   PubMed Web of Science ®Google Scholar